Lloyd Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19K Buy
+29
New +$6.25K ﹤0.01% 400
2026
Q1
– Sell
-2
Closed -$414 – 905
2025
Q4
$414 Buy
+2
New +$400 ﹤0.01% 520
2022
Q1
– Sell
-2
Closed -$296 – 619
2021
Q4
$0 Hold
2
– – ﹤0.01% 432
2021
Q3
$0 Sell
2
-14
-88% -$2.39K ﹤0.01% 397
2021
Q2
$3K Sell
16
-1
-6% -$165 ﹤0.01% 338
2021
Q1
$3K Sell
17
-7
-29% -$1.2K ﹤0.01% 320
2020
Q4
$4K Hold
24
– – ﹤0.01% 268
2020
Q3
$4K Sell
24
-2
-8% -$327 ﹤0.01% 244
2020
Q2
$4K Buy
26
+3
+13% +$471 ﹤0.01% 223
2020
Q1
$3K Hold
23
– – ﹤0.01% 197
2019
Q4
$3K Buy
+23
New +$3.16K ﹤0.01% 276

Other funds holding FBT

Lloyd Advisory Services's FBT Position: Q2 2026 in Review

Lloyd Advisory Services opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 29 shares worth $7.19K. The stake represents ﹤0.01% of the portfolio and ranks #400 among its holdings. This is a return to the name: Lloyd Advisory Services previously reported a position in FBT as recently as Q4 2025.

Lloyd Advisory Services first reported a position in FBT in Q4 2019 and has held it in 11 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Lloyd Advisory Services held 29 shares of First Trust NYSE Arca Biotechnology Index Fund worth $7.19K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Lloyd Advisory Services position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #400 holding.
  • Lloyd Advisory Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and has held it in 11 quarters since.
  • 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.